Clinical Trial Detail

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT05672316
Title	Botensilimab, Balstilimab and Regorafenib for the Treatment of Patients With Microsatellite Stable Metastatic Colorectal Cancer Who Have Progressed on Prior Chemotherapy
Recruitment	Active, not recruiting
Gender	both
Phase	Phase Ib/II
Variant Requirements	Yes
Sponsors	City of Hope Medical Center
Indications	colon adenocarcinoma rectum adenocarcinoma
Therapies	Balstilimab + Botensilimab + Regorafenib
Age Groups:	adult \| senior
Covered Countries	USA